Hepatitis: Hepatitis e vaccination-is HEV 239 the breakthrough?

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 1, 2011, Pages 8-10

  Wedemeyer, Heiner ^a   Pischke, Sven ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E VACCINE; RIBAVIRIN; VIRUS ANTIBODY;

ANTIBODY TITER; CHINESE; DRUG EFFICACY; DRUG SAFETY; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOGENICITY; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS ISOLATION;

CHINA; DOSE-RESPONSE RELATIONSHIP, DRUG; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; RISK FACTORS; TREATMENT OUTCOME; VIRAL HEPATITIS VACCINES;

EID: 78651096926     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.207     Document Type: Review

References (10)

1. Purcell, R. H. & emerson, s. U. Hepatitis e: an emerging awareness of an old disease. J. Hepatol. 48, 494-503 (2008).
2. navaneethan, U., Al Mohajer, M. & shata, M. T. Hepatitis e and pregnancy: understanding the pathogenesis. Liver Int. 28, 1190-1199 (2008).
3. Radha Krishna, Y. et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis e virus hepatitis on cirrhosis. Liver Int. 29, 392-398 (2009).
4. Pischke, s. & wedemeyer, H. Chronic hepatitis e in liver transplant recipients: a significant clinical problem? Minerva Gastroenterol. Dietol. 56, 121-128 (2010).
5. Pischke, s. et al. Hepatitis e virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl. 16, 74-82 (2010).
6. Zhu, F. C. et al. efficacy and safety of a recombinant hepatitis e vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376, 895-902 (2010).
7. shrestha, M. P. et al. safety and efficacy of a recombinant hepatitis e vaccine. N. Engl. J. Med. 356, 895-903 (2007).
8. Zhang, J. et al. Randomized-controlled phase ii clinical trial of a bacterially expressed recombinant hepatitis e vaccine. Vaccine 27, 1869-1874 (2009).
9. Pischke, s. et al. should all patients with autoimmune hepatitis be screened for Hevinfection [abstract]? J. Hepatol. 52 (suppl. 1), s135 (2010).
10. Kamar, n. et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 139, 1612-1618 (2010).